A detailed history of Nordea Investment Management Ab transactions in Eli Lilly & CO stock. As of the latest transaction made, Nordea Investment Management Ab holds 1,015,515 shares of LLY stock, worth $765 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
1,015,515
Previous 918,256 10.59%
Holding current value
$765 Million
Previous $831 Million 8.22%
% of portfolio
1.05%
Previous 1.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$772.14 - $960.02 $75.1 Million - $93.4 Million
97,259 Added 10.59%
1,015,515 $900 Million
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $102 Million - $128 Million
140,669 Added 18.09%
918,256 $831 Million
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $152,195 - $203,615
257 Added 0.03%
777,587 $605 Million
Q4 2023

Jan 10, 2024

SELL
$525.19 - $619.13 $16.1 Million - $19 Million
-30,653 Reduced 3.79%
777,330 $453 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $54.8 Million - $75.6 Million
126,143 Added 18.5%
807,983 $434 Million
Q2 2023

Jul 07, 2023

BUY
$350.74 - $468.98 $115 Million - $154 Million
327,875 Added 92.63%
681,840 $320 Million
Q1 2023

Apr 19, 2023

BUY
$310.63 - $364.82 $12.1 Million - $14.2 Million
38,894 Added 12.34%
353,965 $122 Million
Q4 2022

Feb 08, 2023

SELL
$321.55 - $374.67 $3.5 Million - $4.08 Million
-10,887 Reduced 3.34%
315,071 $115 Million
Q3 2022

Oct 19, 2022

SELL
$296.48 - $337.87 $11.3 Million - $12.8 Million
-37,965 Reduced 10.43%
325,958 $106 Million
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $5.73 Million - $6.73 Million
20,550 Added 5.98%
363,923 $118 Million
Q1 2022

Apr 11, 2022

BUY
$234.69 - $291.66 $2.16 Million - $2.68 Million
9,184 Added 2.75%
343,373 $99.8 Million
Q4 2021

Jan 20, 2022

SELL
$224.85 - $279.04 $71.6 Million - $88.8 Million
-318,364 Reduced 48.79%
334,189 $92.9 Million
Q3 2021

Nov 01, 2021

SELL
$221.6 - $272.71 $145 Million - $178 Million
-652,553 Reduced 50.0%
652,553 $154 Million
Q3 2021

Nov 01, 2021

BUY
$221.6 - $272.71 $144 Million - $177 Million
650,447 Added 99.36%
1,305,106 $302 Million
Q2 2021

Jul 16, 2021

SELL
$180.55 - $233.54 $138 Million - $179 Million
-766,575 Reduced 53.94%
654,659 $150 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $30.1 Million - $39 Million
-183,200 Reduced 11.42%
1,421,234 $263 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $11.9 Million - $15.7 Million
90,966 Added 6.01%
1,604,434 $271 Million
Q3 2020

Nov 09, 2020

SELL
$146.22 - $169.13 $209 Million - $242 Million
-1,430,716 Reduced 48.59%
1,513,468 $220 Million
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $197 Million - $237 Million
1,443,527 Added 96.19%
2,944,184 $483 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $3.06 Million - $3.79 Million
-25,737 Reduced 1.69%
1,500,657 $203 Million
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $15.9 Million - $19.7 Million
148,693 Added 10.79%
1,526,394 $200 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $47.9 Million - $52.1 Million
448,122 Added 48.21%
1,377,701 $156 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $28.4 Million - $33.2 Million
256,341 Added 38.08%
929,579 $103 Million
Q1 2019

May 20, 2019

BUY
$111.31 - $131.02 $19.3 Million - $22.7 Million
173,346 Added 34.68%
673,238 $87.4 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $8.64 Million - $9.68 Million
81,615 Added 19.51%
499,892 $57.8 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $143,729 - $179,636
1,674 Added 0.4%
418,277 $44.9 Million
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $4.7 Million - $5.39 Million
-62,075 Reduced 12.97%
416,603 $35.5 Million
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $1.97 Million - $2.33 Million
26,598 Added 5.88%
478,678 $37 Million
Q4 2017

Feb 12, 2018

BUY
$81.94 - $87.89 $170,844 - $183,250
2,085 Added 0.46%
452,080 $38.2 Million
Q3 2017

Nov 09, 2017

BUY
$77.07 - $85.54 $34.7 Million - $38.5 Million
449,995
449,995 $38.5 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.